Ann Reiff
Nurse Practitioner · Chandler, AZNPI 1982655601
Payments from drug & device makers
Across 205 payments — averaging $19.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$578
- AstraZeneca$488
- Novo Nordisk$466
- Amgen$298
- Bayer$239
- Abbott$214
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,079100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 32 | $578 |
| AstraZeneca | 21 | $488 |
| Novo Nordisk | 27 | $466 |
| Amgen | 15 | $298 |
| Bayer | 13 | $239 |
| Abbott | 6 | $214 |
| Johnson & Johnson(2 entities) | 7 | $200 |
| Lilly USA, LLC | 13 | $196 |
| AbbVie | 10 | $186 |
| Boston Scientific | 3 | $170 |
| Sanofi-aventis U.S. LLC | 6 | $129 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $125 |
| Nalu Medical, Inc. | 3 | $105 |
| Boehringer Ingelheim | 5 | $93 |
| Amarin Pharma, Inc. | 5 | $63 |
| Global Blood Therapeutics, Inc. | 3 | $58 |
| Exact Sciences | 4 | $58 |
| Dexcom, Inc. | 3 | $56 |
| Pfizer | 3 | $53 |
| Astellas Pharma US Inc | 2 | $51 |
| Merck | 3 | $47 |
| CSL Behring | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Bausch Health US, LLC | 1 | $22 |
| Smith+Nephew | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Corcept Therapeutics | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Vistapharm, Inc. | 1 | $14 |
| Bardy Diagnostics, Inc. | 1 | $13 |
| Novartis | 1 | $13 |
How this compares
$4,093 in reported general payments places this provider in the 90th percentile of 1,719 nurse practitioner providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 18 | $24,041 |
| OzempicSemaglutide | 20 | $18,005 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $12,622 |
| Spiriva RespimatTiotropium Bromide | 11 | $8,852 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $5,963 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 98 | $2,549 |
| Rosuvastatin Calcium | 83 | $1,884 |
| Levothyroxine Sodium | 205 | $1,846 |
| Citalopram HbrCitalopram Hydrobromide | 15 | $1,535 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $1,287 |
| Promethazine Hcl | 14 | $1,179 |
| Atorvastatin Calcium | 128 | $1,083 |
| Losartan Potassium | 67 | $1,071 |
| Armour ThyroidThyroid,pork | 13 | $952 |
| Lisinopril | 157 | $885 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat | $93 | $32,89329 claims |
| Novo NordiskOzempic | $466 | $18,00520 claims |
| GSKTrelegy Ellipta | $578 | $12,62211 claims |
| AstraZenecaSymbicort | $488 | $5,96317 claims |
| AbbVieArmour Thyroid | $186 | $95213 claims |
| Teva Pharmaceuticals USA, Inc.Acyclovir | $15 | $25518 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,719 nurse practitioner providers in Arizona.
Other nurse practitioner in Chandler
- Krista ArredondoChandler$133K
- Steven KalfusChandler$43K
- Jacqueline MurphyChandler$24K
- Karen GarciaChandler$13K
- Kerry BerghoffChandler$10K
- Lyn NhoungChandler$9K
- Tamara Rivenburgh-CasillasChandler$8K
- Ann MooreGlendale$2.1M
- Andrea KesslerLitchfield Park$780K
- Sandra KurtinTucson$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.